Clinical trial
Evaluation of HER2 Mutations in Patient Tumors From E2598
NCT00896909 is registered in ClinicalTrials.gov with ECOG-ACRIN Cancer Research Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of HER2 Mutations in Patient Tumors From E2598
- Lead sponsor
- ECOG-ACRIN Cancer Research Group
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 2, 2006
- Completion date
- July 2, 2006
- Enrollment
- 44 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer